Retina/Vitreous News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Sujay Jadhav, CEO of Verana Health, discusses two of the company’s new data collection modules which launched during the AAO meeting.

The FDA granted de novo marketing authorization Valeda Light Delivery System for the treatment of dry age-related macular degeneration, according to a press release from LumiThera.

The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene.

The FDA granted fast track designation to FLQ-101 for the treatment of retinopathy of prematurity, according to a press release from FELIQS.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Oculis CEO Riad Sherif, MD, provides a status report on OCS-01, OCS-02 and OCS-05 eye drops.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, discusses bilateral ABBV-RGX-314 gene therapy for neovascular age-related macular degeneration.

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent Blindness.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Gemmy Cheung, MD, PhD, expresses satisfaction with the effects of sozinibercept in patients with polypoidal choroidal vasculopathy, or PCV.

A biomarker panel of three serum metabolites associated with the onset, severity and progression of age-related macular degeneration may aid in earlier detection and monitoring of disease, according to researchers.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Long of Alcon introduces some of the company’s technologies, including the Voyager direct selective laser trabeculoplasty device.